MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
60 hedge funds and large institutions have $87M invested in Marinus Pharmaceuticals, Inc in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
59% less capital invested
Capital invested by funds: $210M → $87M (-$123M)
Holders
60
Holding in Top 10
2
Calls
$3.6M
Puts
$3.07M
Top Buyers
| 1 | +$4.84M | |
| 2 | +$3.61M | |
| 3 | +$2.48M | |
| 4 |
HT
HAP Trading
New York
|
+$1.45M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$1.37M |
Top Sellers
| 1 | -$8.26M | |
| 2 | -$8.17M | |
| 3 | -$7.55M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$7.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.63M |